35
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations.

      American journal of respiratory and critical care medicine
      Adrenal Cortex Hormones, therapeutic use, Aminoglycosides, Anti-Bacterial Agents, Cystic Fibrosis, drug therapy, therapy, Drug Synergism, Humans, Respiratory Therapy, methods, beta-Lactams

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The natural history of cystic fibrosis lung disease is one of chronic progression with intermittent episodes of acute worsening of symptoms frequently called acute pulmonary exacerbations These exacerbations typically warrant medical intervention. It is important that appropriate therapies are recommended on the basis of available evidence of efficacy and safety. The Cystic Fibrosis Foundation therefore established a committee to define the key questions related to pulmonary exacerbations, review the clinical evidence using an evidence-based methodology, and provide recommendations to clinicians. It is hoped that these guidelines will be helpful to clinicians in the treatment of individuals with cystic fibrosis.

          Related collections

          Author and article information

          Comments

          Comment on this article